Cargando…

Triple-Therapy Trials for Chronic Obstructive Pulmonary Disease: Methodological Considerations in the Mortality Effect

Detalles Bibliográficos
Autores principales:	López-Campos, José Luis, Fernández-Villar, Alberto, Ruano-Ravina, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017588/ https://www.ncbi.nlm.nih.gov/pubmed/33444512 http://dx.doi.org/10.1164/rccm.202012-4386LE

Ejemplares similares

Reply to López-Campos et al.: Triple-Therapy Trials for Chronic Obstructive Pulmonary Disease: Methodological Considerations in the Mortality Effect
por: Lipson, David A., et al.
Publicado: (2021)

Fibromax-based nonalcoholic fatty liver disease in chronic obstructive pulmonary disease patients with obstructive sleep apnea: Methodological considerations
por: Monneret, Denis
Publicado: (2017)

Screening for Chronic Obstructive Pulmonary Disease: Validity and Reliability of a Portable Device in Non-Specialized Healthcare Settings
por: Represas-Represas, Cristina, et al.
Publicado: (2016)

Sociodemographic and Clinical Variables Related to the Overburden of the Informal Caregivers of Patients Hospitalized for Chronic Obstructive Pulmonary Disease Exacerbations
por: Fernández-García, Sara, et al.
Publicado: (2021)

Residential radon and characteristics of chronic obstructive pulmonary disease
por: Pando-Sandoval, Ana, et al.
Publicado: (2022)

Risk factors for chronic obstructive pulmonary disease in never‐smokers: A systematic review
por: Pando‐Sandoval, Ana, et al.
Publicado: (2022)

Escalas pronósticas de morbimortalidad por COVID-19: necesarias pero también fiables
por: Candal-Pedreira, Cristina, et al.
Publicado: (2021)

Clinical Audits in Outpatient Clinics for Chronic Obstructive Pulmonary Disease: Methodological Considerations and Workflow
por: López-Campos, Jose Luis, et al.
Publicado: (2015)

Where Do Chronic Obstructive Pulmonary Disease Patients Die? 8-Year Trend, with Special Focus on Sex-Related Differences
por: Fernández-García, Alberto, et al.
Publicado: (2022)

Exposing Pre–Chronic Obstructive Pulmonary Disease: When Physiology Matters!
por: Neder, J. Alberto, et al.
Publicado: (2021)

P-wave dispersion measurement: Methodological considerations
por: Dilaveris, Polychronis, et al.
Publicado: (2017)

Aortic Pulse Wave Velocity Predicts All-Cause Mortality in Chronic Obstructive Pulmonary Disease
por: Fisk, Marie, et al.
Publicado: (2020)

Apparent Increase in Chronic Obstructive Pulmonary Disease Mortality Is Likely an Artifact of Changes in Documentation and Coding
por: Lindenauer, Peter K., et al.
Publicado: (2021)

Triple therapy in chronic obstructive pulmonary disease: consideration under new evidence
por: Gao, Yong-Hua, et al.
Publicado: (2021)

Cardiovascular Disease and Chronic Obstructive Pulmonary Disease: Adding a Third Dimension to the ABE Global Initiative for Chronic Obstructive Lung Disease 2023 Chronic Obstructive Pulmonary Disease Classification
por: Kostikas, Konstantinos, et al.
Publicado: (2023)

Internet-based surveys: relevance, methodological considerations and troubleshooting strategies
por: Menon, Vikas, et al.
Publicado: (2020)

Biomarkers of Right Ventricular–Pulmonary Coupling in Chronic Obstructive Pulmonary Disease
por: Mehmood, Muddassir
Publicado: (2019)

Ultrasonography in Chronic Obstructive Pulmonary Disease: Fact or Fiction?
por: Alqahtani, Jaber S, et al.
Publicado: (2020)

Reply to Fisk and Wilkinson: Aortic Pulse Wave Velocity Predicts All-Cause Mortality in Chronic Obstructive Pulmonary Disease
por: Crim, Courtney, et al.
Publicado: (2020)

Inteligencia artificial en radiología torácica. ¿Un reto en tiempos de la COVID-19?
por: Corbacho Abelaira, María Dolores, et al.
Publicado: (2021)

Reply to Lindenauer et al.: Apparent Increase in Chronic Obstructive Pulmonary Disease Mortality Is Likely an Artifact of Changes in Documentation and Coding
por: Puebla Neira, Daniel A., et al.
Publicado: (2021)

Deconvoluting Chronic Obstructive Pulmonary Disease: Are B Cells the Frontrunners?
por: Polverino, Francesca
Publicado: (2019)

Ultrasonography of diaphragm in chronic obstructive pulmonary disease: Unanswered questions
por: Hadda, Vijay, et al.
Publicado: (2020)

Opioids for Dyspnea in Chronic Obstructive Pulmonary Disease: Short on the Details
por: Vozoris, Nicholas T.
Publicado: (2021)

Health-related quality of life in chronic obstructive pulmonary disease
por: Rai, Deependra Kumar
Publicado: (2021)

Definition of Chronic Obstructive Pulmonary Disease: Occupational Environmental Contribution
por: Harber, Philip
Publicado: (2022)

Patients with Chronic Obstructive Pulmonary Disease Require More Than Pulmonary Rehabilitation to Improve Outcomes
por: Prieto-Centurion, Valentin, et al.
Publicado: (2019)

Chronic obstructive pulmonary disease mortality trends in Spain, 1980-2020
por: Cayuela, Lucia, et al.
Publicado: (2023)

Pharmacotherapy for Chronic Obstructive Pulmonary Disease: Molecules and Delivery Are Equally Important
por: Mahler, Donald A., et al.
Publicado: (2020)

Pre–Chronic Obstructive Pulmonary Disease: Toward the Limits of the Spirometric Funnel
por: Wouters, Emiel F. M.
Publicado: (2021)

Asthma with a Smoking History and Pre–Chronic Obstructive Pulmonary Disease
por: Thomson, Neil C.
Publicado: (2021)

Asthma and Chronic Obstructive Pulmonary Disease: Just Old Friends or Relatives?
por: Polverino, Francesca, et al.
Publicado: (2021)

Malnutrition associated with readmission in elderly patients with chronic obstructive pulmonary disease
por: Zhao, Ting, et al.
Publicado: (2023)

Insomnia in chronic obstructive pulmonary disease and associations with healthcare utilization and costs
por: Luyster, Faith S., et al.
Publicado: (2023)

Lack of Bacterial Colonization Measure in Randomized Controlled Trial on Inhaled Corticosteroids Effect in Patients with Chronic Obstructive Pulmonary Disease
por: Martinez-Garcia, Miguel Angel, et al.
Publicado: (2021)

Foreign Body Aspiration-induced Unusual Exacerbation of Chronic Obstructive Pulmonary Disease
por: Ren, Xiao-Xia, et al.
Publicado: (2016)

Peak Inspiratory Flow Rate: An Emerging Biomarker in Chronic Obstructive Pulmonary Disease
por: Mahler, Donald A.
Publicado: (2019)

Reply to Polverino: Deconvoluting Chronic Obstructive Pulmonary Disease: Are B Cells the Frontrunners?
por: Ladjemi, Maha Zohra, et al.
Publicado: (2019)

Cardiovascular and Chronic Obstructive Pulmonary Disease Therapeutics: Two Paths, One Destination?
por: Mehmood, Muddassir
Publicado: (2020)

The Role of Eosinophils during the Withdrawal of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease
por: Wang, Cheng-Yi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o0a856o2r6vpumdgfthdb9gfn5